Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison C Nugent

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Archives of General Psychiatry|August 4, 2004
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controlsAlexander Neumeister, Allison C Nugent, Tracy Waldeck, et al.
The Journal of Clinical Psychiatry|June 25, 2008
Reduced posterior hippocampal volume in posttraumatic stress disorderOmer Bonne, Meena Vythilingam, Masatoshi Inagaki, et al.
Therapeutic Advances in Chronic Disease|May 9, 2015
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective reviewNicolas D Iadarola, Mark J Niciu, Erica M Richards, et al.
Biological Psychiatry|August 1, 2006
Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomographyDara M Cannon, Masanori Ichise, Stephen J Fromm, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
Archives of General Psychiatry|July 5, 2006
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorderDara M Cannon, Richard E Carson, Allison C Nugent, et al.
Neuroimage|November 1, 2005
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometryAllison C Nugent, Michael P Milham, Earle E Bain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2013
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionAllison C Nugent, Earle E Bain, Paul J Carlson, et al.
Revista De Psiquiatria Clinica|June 18, 2015
Biomarkers in mood disorders research: developing new and improved therapeuticsMark J Niciu, Daniel C Mathews, Dawn F Ionescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Archives of General Psychiatry|August 4, 2004
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controlsAlexander Neumeister, Allison C Nugent, Tracy Waldeck, et al.
The Journal of Clinical Psychiatry|June 25, 2008
Reduced posterior hippocampal volume in posttraumatic stress disorderOmer Bonne, Meena Vythilingam, Masatoshi Inagaki, et al.
Therapeutic Advances in Chronic Disease|May 9, 2015
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective reviewNicolas D Iadarola, Mark J Niciu, Erica M Richards, et al.
Biological Psychiatry|August 1, 2006
Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomographyDara M Cannon, Masanori Ichise, Stephen J Fromm, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
Archives of General Psychiatry|July 5, 2006
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorderDara M Cannon, Richard E Carson, Allison C Nugent, et al.
Neuroimage|November 1, 2005
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometryAllison C Nugent, Michael P Milham, Earle E Bain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2013
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionAllison C Nugent, Earle E Bain, Paul J Carlson, et al.
Revista De Psiquiatria Clinica|June 18, 2015
Biomarkers in mood disorders research: developing new and improved therapeuticsMark J Niciu, Daniel C Mathews, Dawn F Ionescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Pageof 10